|
EIF2AK2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.319540E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.99569999999439E-05 |
| Normal-vs-Stage2 |
3.152800E-01 |
| Normal-vs-Stage3 |
4.029800E-01 |
| Normal-vs-Stage4 |
3.650800E-01 |
| Stage1-vs-Stage2 |
2.156600E-01 |
| Stage1-vs-Stage3 |
8.257900E-03 |
| Stage1-vs-Stage4 |
5.668600E-01 |
| Stage2-vs-Stage3 |
1.849550E-01 |
| Stage2-vs-Stage4 |
7.994800E-01 |
| Stage3-vs-Stage4 |
2.247600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.160800E-04 |
| Normal-vs-AfricanAmerican |
1.510280E-02 |
| Normal-vs-Asian |
8.158000E-01 |
| Caucasian-vs-AfricanAmerican |
8.671800E-01 |
| Caucasian-vs-Asian |
4.733600E-01 |
| AfricanAmerican-vs-Asian |
4.942400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.67680000013371E-07 |
| Normal-vs-Female |
2.137600E-01 |
| Male-vs-Female |
1.23780000005347E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.392500E-02 |
| Normal-vs-Extreme_Weight |
1.05130000005449E-06 |
| Normal-vs-Obese |
1.420800E-01 |
| Normal-vs-Extreme_Obese |
6.997500E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.018200E-01 |
| Normal_Weight-vs-Obese |
5.319400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.130800E-01 |
| Extreme_Weight-vs-Obese |
3.681200E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.665600E-01 |
| Obese-vs-Extreme_Obese |
4.887900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.359200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.171800E-02 |
| Normal-vs-Age(61-80Yrs) |
1.83586999999985E-05 |
| Normal-vs-Age(81-100Yrs) |
9.763800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.427400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.214300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.092300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.393510E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.862300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.736400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.76989999989274E-07 |
| Normal-VS-Type2 PRCC |
1.952780E-01 |
| Normal-VS-KIRP CIMP |
5.622500E-02 |
| Normal-VS-Unclassified PRCC |
8.392200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.319700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.377800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.144600E-03 |
| Type2 PRCC-VS-KIRP CIMP |
4.741800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.848400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.732300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.424300E-04 |
| Normal-vs-N1 |
9.444400E-02 |
| Normal-vs-N2 |
7.601600E-01 |
| N0-vs-N1 |
2.480900E-03 |
| N0-vs-N2 |
4.362600E-01 |
| N1-vs-N2 |
3.531200E-01 |
|
|
